To include your compound in the COVID-19 Resource Center, submit it here.

Akouos licenses gene therapy tech from Massachusetts Eye and Ear

Newco Akouos Inc. (Boston, Mass.) acquired an exclusive license to a vector platform from Massachusetts Eye and Ear (Boston, Mass.) and Lonza Group Ltd. (SIX:LONN) to develop gene therapies

Read the full 299 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE